Earnings NewsHealthcareResMed EPS in-line, misses on revenueApr. 23, 2015 4:20 PM ETResMed Inc. (RMD) StockBy: Mohit Manghnani, SA News Editor ResMed (NYSE:RMD): FQ3 EPS of $0.65 in-line. Revenue of $422.5M (+6.2% Y/Y) misses by $2.29M. Shares -0.9%. Press Release Recommended For YouMore Trending NewsSee More »About RMD StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgRMD--ResMed Inc.Trending AnalysisTrending News